Shares shifted sharply as investors continued to pile into Critical Metals Corp. (CRML), pushing the stock to $7.60 — up 12.9% — three days after the company announced that lab tests dissolved more than 99% of mineral concentrate from its Greenland rare-earth project into 19 separate high-purity products. The rally extends a week that has already added roughly 20% to the share price, but the gap between a promising test tube and a functioning mine-to-refinery operation remains enormous.
• A Lab Win That Still Needs a Factory Behind It
On September 16, Critical Metals announced its "mine-to-metals strategy" for the Tanbreez Rare Earth Project in Greenland.
The breakthrough: greater than 99% dissolution of eudialyte concentrate into 19 ultra-high-purity rare earth products. That means the company can chemically break apart the raw mineral almost completely — a step many competitors have struggled with. But dissolution in a lab is not commercial-scale production, and the market is pricing in execution that has not yet happened.
• The Revenue Projections Sound Huge — Read the Fine Print
A refinery study for the proposed Romanian joint venture facility projects annual revenue of approximately $2.2 billion before operating costs, taxes, and capital recovery, with a preliminary capital expenditure estimate of $1.85 billion.
Current modeling indicates a net present value (the project's worth in today's dollars, discounted at 10%) of approximately $4.5 billion, a return rate of roughly 55%, and a projected payback period of about two years. Those are eye-catching numbers, but they rest on modeled prices — the company assumes a concentrate value of roughly $4,000 per ton — and a refinery that does not yet exist.
• A Pending Merger Adds Both Opportunity and Risk
Shareholder meetings to vote on the $835 million acquisition of European Lithium are scheduled for October 22, 2026.
An independent expert judged the deal "not fair but reasonable" for European Lithium holders — a lukewarm endorsement. European Lithium controls the corporate structure that would give Critical Metals a cleaner path forward on Tanbreez, so a rejection would complicate the entire refinery roadmap.
• Valuation Has Outrun the Asset's Stage
With roughly 146.9 million shares outstanding, the stock at $7.60 implies a market value above $1.1 billion for a company with zero revenue and a project still years from production. Tanbreez's heavy rare-earth concentration of approximately 27% far exceeds typical industry standards, giving it genuine strategic appeal amid Western efforts to reduce dependence on Chinese processing. But strategic appeal is not cash flow — and between the $1.85 billion capex bill and a merger vote five weeks away, plenty can still go wrong.